TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Biolidics Ltd. ( (SG:8YY) ) has provided an update.
Embracing Future Holdings Limited has completed the allotment and issuance of new ordinary shares, increasing its total issued and paid-up share capital from 1,690,758,836 to 1,733,441,815 shares. This issuance, which includes various categories of shares such as Yuan Sign-On Shares and ECA Shares, is expected to be listed on the Catalist of the SGX-ST. The completion of this process marks a significant step in the company’s capital expansion strategy, potentially impacting its market positioning and offering new opportunities for stakeholders.
More about Biolidics Ltd.
Embracing Future Holdings Limited, formerly known as Biolidics Limited, is a company incorporated in Singapore. The company operates in the biotechnology sector, focusing on the development and commercialization of medical technology products. It is involved in the issuance of new ordinary shares to expand its share capital.
Average Trading Volume: 1,794,110
Technical Sentiment Signal: Hold
Current Market Cap: S$37.2M
For a thorough assessment of 8YY stock, go to TipRanks’ Stock Analysis page.

